Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
NCT01550549
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Mild Cognitive Impairment
Neurodegenerative Diseases
Interventions
DRUG:
florbetapir F 18
Sponsor
Avid Radiopharmaceuticals